SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-142000
Filing Date
2023-05-11
Accepted
2023-05-11 16:05:56
Documents
14
Period of Report
2023-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d471457d8k.htm   iXBRL 8-K 25361
2 EX-99.1 d471457dex991.htm EX-99.1 74353
6 GRAPHIC g471457g0510134958256.jpg GRAPHIC 3193
  Complete submission text file 0001193125-23-142000.txt   235200

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iobt-20230511.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20230511_lab.xml EX-101.LAB 17911
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20230511_pre.xml EX-101.PRE 11239
8 EXTRACTED XBRL INSTANCE DOCUMENT d471457d8k_htm.xml XML 3330
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 23910927
SIC: 2834 Pharmaceutical Preparations